# Dendreon Pharmaceuticals LLC – FDA Inspection, Mar 25, 2026

Source: https://www.keypedia.com/records/fda_inspections/dendreon-pharmaceuticals-llc/18d0f24c-cd63-43db-ac7c-9cb2177b0278
Source feed: FDA_Inspections

> FDA inspection 1303248 of Dendreon Pharmaceuticals LLC, March 25, 2026. 9 citations under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1303248
- Company Name: Dendreon Pharmaceuticals LLC
- Inspection Date: 2026-03-25
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Los Angeles District Office
- Citation Count: 9

## Related Documents

- [FDA Inspection 1214688 - 2023-08-10](https://www.keypedia.com/records/fda_inspections/dendreon-pharmaceuticals-llc/4fe7a753-79ef-4ea0-be81-129f0bb9e16c)
- [FDA Inspection 1109236 - 2019-11-08](https://www.keypedia.com/records/fda_inspections/dendreon-pharmaceuticals-llc/54955f40-a4c2-4bc9-981a-fc18dba66ec3)
- [FDA Inspection 1038072 - 2018-01-19](https://www.keypedia.com/records/fda_inspections/dendreon-pharmaceuticals-llc/c7e1845f-cb5b-449a-9b17-557e9b813d17)
- FDA Inspection 961300 - 2016-01-22
- FDA Inspection 848259 - 2012-11-15

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/benny-mathews/a0c2f18f-b528-492e-8763-17943a4cbd11)
- [Issuing Officer](https://www.keypedia.com/people/emily-b-camire/dff5f4c6-bcbe-4ef1-ac0b-1b2701b311ef)
- [Issuing Officer](https://www.keypedia.com/people/esther-a-ofori/98108fae-1e09-4849-bceb-18e69dff7ba4)
- [FDA Personnel](https://www.keypedia.com/people/lizaida-perez/686fbdca-bfd7-4a73-990a-d8a97e6b88b7)
- [FDA Associated Person](https://www.keypedia.com/people/sony-mathews/4d42379f-1245-494c-8c19-6cefa4e560a5)

Company: https://www.keypedia.com/companies/dendreon-pharmaceuticals-llc/68ccd67e-0a3a-41cb-ae30-e9e10a6eaef5

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b
